NCT06508580Completed
Optimizing Self-Monitoring Feedback for the Treatment of Obesity
Optimizing Self-Monitoring Feedback Delivery for the Treatment of Obesity
Source: ClinicalTrials.gov · Last updated 8 Apr 2025
Brief summary (registry, in English)
Self-monitoring (of weight, intake, and activity) is a core component in evidence-based lifestyle interventions for obesity. Research has shown that interventionist feedback increases adherence to self-monitoring and improves weight loss outcomes; however, little empirical evidence exists on how this feedback should be provided. This research study aims to optimize the provision of self-monitoring feedback.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 28 (actual)
- First submitted
- 12 Jul 2024
- Start date
- 23 Jul 2024
- Primary completion date
- 3 Feb 2025
- Lead sponsor
- University of Florida
- Diseases
- Obesity
- NCT number
- NCT06508580
What you commit to
- Study type: Interventional
- Participants enrolled: 28
- From 23 Jul 2024 to the primary completion date, 3 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current use of weight loss medications, or use of weight loss medications in the 6 months prior to initial pre-screening
- Weight loss of ≥ 10 lbs in the 6 months prior to initial pre-screening
Other illness
- History of bariatric surgery or plans to obtain bariatric surgery during the study period
- Lack of written approval for participation from potential participant's physician if the participant has been diagnosed with diabetes, hypertension, or has a history of coronary heart disease
- Medical conditions that contraindicate weight loss or prevent completion of the study (e.g., current diagnosis of cancer or terminal illness, dementia, etc.)
- Self-reported eating disorder within past 5 years
- Failure to complete baseline assessment measures
- Failure to complete at least 5 out of 7 days of self-monitoring dietary and weight self-monitoring during the behavioral run-in period
- Other conditions which in the opinion of the Principal Investigator would adversely affect participation in the study
Other
- Weight \> 175 kg (due to a weight limit of the study-provided scale)
- Smartphone device owned deemed incompatible with the Fitbit App
- Currently participating in a weight-loss program
- Physical limitations that prevent walking 1/4 mile without stopping
- Use of a pacemaker or other implanted medical device
- Currently pregnant
- Currently breastfeeding
- Less than 1-year post-partum
- Plans to become pregnant within the study period
- One or more study participants living in the household (enrollment limited to one participant per household)
- Unable to complete the 17-week study (due to plans to relocate during the study period, etc.)
- Unable or unwilling to provide informed consent
- Unable to read English at the 5th grade level
- Unwilling to accept random assignment
- Unable or unwilling to download the study smartphone applications, wear the physical activity monitor, or use the study e-scale
Who the study is looking for
- Age ≥ 18 years
- BMI ≥ 30.0 kg/m2
- ≤ 175 kg (due to scale limit)
- Own a smartphone (Apple iPhone running iOS 15 or higher or Android smartphone running Android 10 or higher) with a cellular and data plan
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Florida Coordinator of this site? Confirm its status | Gainesville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.